Clinical trial

Follow-up Protocol to Collect the Outcome and Safety of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Study P06029 (Phase 3; Protocol No. P06031)

Name
P06031
Description
The purpose of this follow-up study is to collect the outcome and safety of FTET cycles after the embryos are cryopreserved in P06029 (NCT01144416). P06029 was a study in which a single injection of corifollitropin alfa (SCH 900962) was compared with daily recombinant follicle stimulating hormone (recFSH) injections in women aged 35 to 42 years undergoing controlled ovarian stimulation (COS) prior to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Trial arms
Trial start
2010-06-02
Estimated PCD
2013-07-24
Trial end
2014-04-29
Status
Completed
Phase
Early phase I
Treatment
Corifollitropin alfa
Single injection of 150 μg corifollitropin alfa administered under protocol P06029
Arms:
Corifollitropin alfa 150 μg
recFSH (follitropin beta)
Daily recFSH 300 IU administered under protocol P06029.
Arms:
recFSH 300 IU
Other names:
Follistim® AQ Cartridge
Size
307
Primary endpoint
Percentage of Participants With ≥1 Vital Pregnancy (Cumulative Vital Pregnancy Rate)
Assessed at least 35 days after ET in COS cycle in Base Study P06029 or an FTET cycle in Follow-Up Study P06031 (up to 2 years)
Eligibility criteria
Inclusion Criteria: * Participant must have provided written informed consent for the trial. * Participant must have cryopreserved embryo(s) in trial P06029 (NCT01144416) of which at least one embryo is thawed for use in a subsequent FTET cycle.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 307, 'type': 'ACTUAL'}}
Updated at
2024-05-22

1 organization

2 products

1 indication

Organization
Organon and Co
Indication
infertility
Product
recFSH